BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19829151)

  • 1. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.
    Boggs SR; Cunnion KM; Raafat RH
    Pediatrics; 2011 Nov; 128(5):e1289-92. PubMed ID: 21969285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hemolytic crisis after ceftriaxone administration.
    Goyal M; Donoghue A; Schwab S; Hasbrouck N; Khojasteh S; Osterhoudt K
    Pediatr Emerg Care; 2011 Apr; 27(4):322-3. PubMed ID: 21467885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-induced hemolytic anemia: case report and review of literature.
    Northrop MS; Agarwal HS
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone induced acute multi-organ failure syndrome in a Saudi boy with sickle cell disease.
    Al-Hawsawi ZM; Turkistani WA; Al-Aidaros MA; Al-Harbi DL
    Saudi Med J; 2010 Jul; 31(7):826-8. PubMed ID: 20635020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.
    Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC
    Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration.
    Corso M; Ravindranath TM
    Pediatr Emerg Care; 2005 Feb; 21(2):99-101. PubMed ID: 15699818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection.
    Quillen K; Lane C; Hu E; Pelton S; Bateman S
    Pediatr Infect Dis J; 2008 Apr; 27(4):357-8. PubMed ID: 18316983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone-induced immune hemolytic anemia.
    Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
    Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
    Moallem HJ; Garratty G; Wakeham M; Dial S; Oligario A; Gondi A; Rao SP; Fikrig S
    J Pediatr; 1998 Aug; 133(2):279-81. PubMed ID: 9709722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.
    Viner Y; Hashkes PJ; Yakubova R; Segal-Kupershmit D; Luder AS
    Pediatr Infect Dis J; 2000 Jan; 19(1):83-5. PubMed ID: 10643859
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced immune hemolytic anemia.
    Garratty G
    Clin Adv Hematol Oncol; 2010 Feb; 8(2):98-101. PubMed ID: 20386530
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
    Martin ME; Laber DA
    Am J Hematol; 2006 Mar; 81(3):186-8. PubMed ID: 16493619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.
    Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H
    Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.
    Bernini JC; Mustafa MM; Sutor LJ; Buchanan GR
    J Pediatr; 1995 May; 126(5 Pt 1):813-5. PubMed ID: 7752012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma.
    Pecker LH; Timsar A; Pary PP; Denomme GA; Criss VR; Luban NL; Hwang EI; Wong EC
    Pediatr Blood Cancer; 2016 Oct; 63(10):1852-5. PubMed ID: 27304608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.
    Kumar S; Bansal R; Bansal P; Dhamija RK; Neurology D
    Perm J; 2020; 24():. PubMed ID: 31905339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.